People · Operator
Named in public records as an officer, director or promoter · active 2023–2025 · Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kastle Biopartners II LP | — | Other | Series A | $14.4M | $53.2M | 2025 |
| Kastle BioPartners LP | — | Other | Series A | $7.3M | $51.7M | 2023 |
Colby Kash at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Colby Kash on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Kash | 2 | 4 |
| Josh Sharan | 1 | 1 |
| Jeffrey Serbin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.